Characterisation of cotadutide's dual GLP‐1/glucagon receptor agonistic effects on glycaemic control using an in vivo human glucose regulation quantitative systems pharmacology model

Documenti analoghi

• From In Vitro Efficacy to Long‐Term HbA1c Response for GLP‐1R/GlucagonR Agonism Using the 4GI‐HbA1c Systems Model
  di: Rolien Bosch, et al.
  Pubblicazione: (2025)
• Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists
  di: W. Timothy Garvey, et al.
  Pubblicazione: (2024)
• Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development
  di: Martijn van Noort, et al.
  Pubblicazione: (2024)
• Time‐varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modeling
  di: Sebastiaan Camiel Goulooze, et al.
  Pubblicazione: (2024)
• Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
  di: Iskandar Idris
  Pubblicazione: (2024)